NCT06399991

Brief Summary

The main objective of the proposed study is to evaluate the impact of the combined leadership alignment + champion implementation strategy compared to a champion strategy alone, on integration of an evidence-based mental health treatment model into multiple medical care settings.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,080

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
16mo left

Started Apr 2025

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Apr 2025Sep 2027

First Submitted

Initial submission to the registry

May 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 6, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

April 8, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

May 4, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

May 1, 2024

Last Update Submit

May 1, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Proportion of screening-eligible visits at which patients were screened for mental health

    Fidelity of mental health screening will be defined as the proportion of visits eligible for anxiety and depression screening that included the screening. Screening-eligible visits are visits where the patient is not currently receiving mental health treatment. Completion of anxiety and depression screening is defined as completing both the GAD-2 and the Patient Health Questionnaire-2 (PHQ-2), and, if one or both are ≥3, also completing the relevant longer instrument(s) - GAD-7 and PHQ-9. This will be measured utilizing clinical administrative data abstraction.

    Over the 12 months of the randomized period

  • Proportion of visits at which patients endorsed suicidal ideation at which a suicide risk assessment was completed

    Fidelity of safety assessment will be defined as the proportion of patient visits with a PHQ-9 question 9 score \>0 that included a documented Suicide Risk Assessment result. This will be measured utilizing clinical administrative data abstraction.

    Over the 12 months of the randomized period

  • Proportion of patients who were appropriately initiated on mental health treatment

    Fidelity of mental health treatment initiation will be defined as the proportion of patients eligible for mental health treatment who actually started either Friendship Bench counseling or medication within 30 days of identification. Eligibility for mental health treatment is defined as having a GAD-7 or PHQ-9 total score of 5 or above. This will be measured utilizing clinical administrative data abstraction.

    Over the 12 months of the randomized period

  • Proportion of follow-up visits at which clinical decisions followed mental health treatment guidelines

    Fidelity of follow-up treatment will be defined as the proportion of follow-up appointments in the first three months of mental health treatment where the clinical treatment decision follows the mental health treatment guidelines. For Friendship Bench (FB) counseling, fidelity is achieved by continuing FB until completion or switching to medication. For medication, if the follow-up GAD-7/PHQ-9 score is \<5, fidelity is achieved by continuing treatment; if the follow-up GAD-7/PHQ-9 score is ≥5, fidelity is achieved by continuing treatment and increasing dose. This will be measured utilizing clinical administrative data abstraction.

    Over the 12 months of the randomized period

  • Proportion of Counseling sessions meeting Fidelity Threshold

    Fidelity of Friendship Bench counseling will be defined as the proportion of Friendship Bench counseling sessions receiving a score of ≥3 (Satisfactory) on ≥8 of 10 fidelity checklist items.

    Over the 12 months of the randomized period

Secondary Outcomes (2)

  • Proportion of patients achieving mental health remission

    3 months after participant enrollment

  • Proportion of patients achieving chronic condition control

    6 months after participant enrollment

Study Arms (2)

Adapted LOCI leadership and climate alignment strategy plus champion strategy

EXPERIMENTAL

Implementation of LOCI strategy (adapted for the Malawian context) plus the champion strategy (enhanced usual care- usual outpatient care enhanced with use of trained champions).

Behavioral: Adapted LOCI leadership and climate alignment strategy plus champion strategy

Champion strategy

ACTIVE COMPARATOR

Enhanced usual care. Continue with usual outpatient care, enhanced with use of trained champions.

Behavioral: Champion strategy

Interventions

The champion strategy involves identifying champions within each district who are trained and supported as change agents through training and supervision.

Champion strategy

The LOCI strategy involves engaging with district health leadership through data and feedback, leadership development trainings, coaching, and alignment strategy activities to align leadership and climate in support of implementing the evidence-based mental health package. The champion strategy involves identifying champions within each district who are trained and supported as change agents through training and supervision.

Adapted LOCI leadership and climate alignment strategy plus champion strategy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • Patient receiving medical care in participating district who screened positive for elevated common mental disorder symptoms that day or in the preceding month.

You may not qualify if:

  • \<18 years old
  • Not currently a patient receiving medical care in participating district who screened positive for elevated common mental disorder symptoms that day or in the preceding month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Chiradzulu District Hospital

Chiradzulu, Malawi

RECRUITING

Dedza District Hospital

Dedza, Malawi

RECRUITING

Kasungu District Hospital

Kasungu, Malawi

RECRUITING

Machinga District Hospital

Machinga, Malawi

RECRUITING

Mangochi District Hospital

Mangochi, Malawi

RECRUITING

Mchinji District Hospital

Mchinji, Malawi

RECRUITING

Mulanje District Hospital

Mulanje, Malawi

RECRUITING

Mzimba South District Hospital

Mzimba, Malawi

RECRUITING

Nkhata Bay District Hospital

Nkhata Bay, Malawi

RECRUITING

Ntcheu District Hospital

Ntcheu, Malawi

RECRUITING

Phalombe District Hospital

Phalombe, Malawi

RECRUITING

Salima District Hospital

Salima, Malawi

RECRUITING

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Brian Pence

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Brian Pence, PhD, MPH

CONTACT

Kazione Kulisewa, MBBS MMed

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2024

First Posted

May 6, 2024

Study Start

April 8, 2025

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

September 30, 2027

Last Updated

May 4, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Deidentified individual data will be uploaded to the National Institute of Mental Health (NIMH) Data Archive (NDA) following a 6-month upload schedule. Data will be available for request from the NDA beginning one year after the grant end date specified on the first Notice of Award. Any subject-level data and the associated analyzed data used in a journal publication will be shared at the time of publication, if the publication occurs before the one-year automatic share date.

Time Frame
All NIMH National Data Archive collection data are shared automatically one year after the grant end date specified on the first Notice of Award.
Access Criteria
Access to data for research purposes will be provided through an NIMH Data Archive Data Access Committee. Investigators and institutions seeking data from NDA will be expected to meet data security measures and will be asked to submit a Data Use Certification, which is cosigned by the investigator and the designated Institutional Official(s) at the NIH-recognized sponsoring institution with a current Federal Wide Assurance.
More information

Locations